KIRKLAND DICKEY: Open Payments
NPI 1114589884 · PINE HALL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 84 payments from 16 companies in 2025. Trend: 2023 $2,210 · 2024 $2,016 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $357 |
| AstraZeneca Pharmaceuticals LP | 14 | $270 |
| ABBVIE INC. | 20 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Viatris Specialty LLC | 5 | $93 |
| PFIZER INC. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 2 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $54 |
Products named: CAPLYTA, VRAYLAR, JARDIANCE, REXULTI, YUPELRI, AIRSUPRA, BREZTRI, FARXIGA.
Industry payments across NC — which companies pay providers there.
